Can Cilta-Cel Redefine Outcomes in Multiple Myeloma?

Source: Pharmacy Times articles

CARTITUDE-1 data show one-third of patients treated with cilta-cel
remain progression-free at 5 years without maintenance.

You must be logged in to post a comment.